B

Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML

Watchlist Manager
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Watchlist
Price: 5.8 PLN 1.67% Market Closed
Market Cap: zł378.5m

Net Margin

14.1%
Current
Improving
by 1%
vs 3-y average of 13.1%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.1%
=
Net Income
zł7.6m
/
Revenue
zł53.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.1%
=
Net Income
zł7.6m
/
Revenue
zł53.8m

Peer Comparison

Country Company Market Cap Net
Margin
PL
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
407.5m PLN
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.4B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
169B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.3B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.1B USD
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.8B USD
Loading...

Market Distribution

Higher than 77% of companies in Poland
Percentile
77th
Based on 886 companies
77th percentile
14.1%
Low
-9 940 700% — -3.7%
Typical Range
-3.7% — 9.1%
High
9.1% — 196 605.3%
Distribution Statistics
Poland
Min -9 940 700%
30th Percentile -3.7%
Median 2.9%
70th Percentile 9.1%
Max 196 605.3%

Biomed Lublin Wytwornia Surowic i Szczepionek SA
Glance View

Market Cap
378.5m PLN
Industry
Biotechnology

Biomed Lublin Wytwornia Surowic i Szczepionek SA engages in the manufacture of pharmaceutical products. The company is headquartered in Lublin, Woj. Lubelskie and currently employs 223 full-time employees. The company went IPO on 2011-07-29.

BML Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
14.1%
=
Net Income
zł7.6m
/
Revenue
zł53.8m
What is Biomed Lublin Wytwornia Surowic i Szczepionek SA's current Net Margin?

The current Net Margin for Biomed Lublin Wytwornia Surowic i Szczepionek SA is 14.1%, which is above its 3-year median of 13.1%.

How has Net Margin changed over time?

Over the last 3 years, Biomed Lublin Wytwornia Surowic i Szczepionek SA’s Net Margin has increased from 8.6% to 14.1%. During this period, it reached a low of 5.7% on Sep 30, 2020 and a high of 14.1% on May 1, 2023.

Back to Top